Viavi price target raised to $18 from $15 at Susquehanna

Susquehanna raised the firm’s price target on Viavi (VIAV) to $18 from $15 and keeps a Positive rating on the shares. The firm raised its esitmates following Q1 results which were better than expected as the company continues to benefit from increasing hyperscale spending, particularly in fiber applications.